Kathryn A. Selby
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Expanding Vamorolone Treatment Access for Canadians with Duchenne Muscular Dystrophy.
Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Published: July 13, 2026
Vamorolone Safety, Pharmacokinetics, and Exploratory Efficacy in Duchenne Muscular Dystrophy: A Phase II, Nonrandomized, Multiple-Dose Study in 2-<4-Year-Old Boys.
Journal: Neurology
Published: May 15, 2026
Building capacity for patient-engagement in neuromuscular disease research: A network project.
Journal: Journal of neuromuscular diseases
Published: December 16, 2025
Evaluating Empowerment in Adolescents with a Disability and/or Chronic Condition from Neurology and Orthopedic Clinics: A Mixed-Methods Study.
Journal: Journal of pediatrics. Clinical practice
Published: December 04, 2025
Results of a phase II open-label, multiple-dose study of vamorolone (VBP15-006) in 7- to < 18-year-old boys with duchenne muscular dystrophy.
Journal: Journal of neurology
Published: November 11, 2025
Correction: Identity development and adaptation in adolescents with genetic conditions: a qualitatively oriented mixed-methods study to develop strategies for optimizing clinical genetics services.
Journal: Orphanet journal of rare diseases
Published: September 19, 2025
Financial Toxicity and Its Determinants in Individuals Living With Inherited and Acquired Neuromuscular Disorders: The BIND Study.
Journal: Neurology
Published: August 20, 2025
Counting the Cost: The Hidden Financial Realities of Neuromuscular Disease Through Patient and Family Perspectives.
Journal: Health expectations : an international journal of public participation in health care and health policy
Published: August 08, 2025
Adrenal Suppression in Duchenne Muscular Dystrophy: Management Strategies Incorporating Novel Steroid Vamorolone.
Journal: Journal of the Endocrine Society
Published: June 18, 2025
Respiratory and Bulbar Support in Spinal Muscular Atrophy Type I Treated with Nusinersen.
Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Published: May 13, 2025
Feasibility of a Home-Based Exergaming Intervention for Youth With Spinal Muscular Atrophy.
Journal: Muscle & nerve
Published: January 28, 2025
Empowerment in Adolescent Patients with a Disability/Chronic Condition: A Scoping Review.
Journal: Children (Basel, Switzerland)
Published: November 22, 2024
Last Updated: 09/26/2026